[HTML][HTML] Chagas disease and transfusion medicine: a perspective from non-endemic countries

A Angheben, L Boix, D Buonfrate, F Gobbi… - Blood …, 2015 - ncbi.nlm.nih.gov
In the last decades, increasing international migration and travel from Latin America to
Europe have favoured the emergence of tropical diseases outside their “historical” …

[HTML][HTML] Improving the safety of whole blood-derived transfusion products with a riboflavin-based pathogen reduction technology

S Yonemura, S Doane, S Keil, R Goodrich… - Blood …, 2017 - ncbi.nlm.nih.gov
Worldwide safety of blood has been positively impacted by technological, economic and
social improvements; nevertheless, growing socio-political changes of contemporary society …

Primary hemostatic capacity of whole blood: a comprehensive analysis of pathogen reduction and refrigeration effects over time

HF Pidcoke, SJ McFaul, AK Ramasubramanian… - …, 2013 - Wiley Online Library
Background Whole blood (WB) has been used in combat since World War I as it is readily
available and replaces every element of shed blood. Component therapy has become …

Pathogen reduction and blood transfusion safety in Africa: strengths, limitations and challenges of implementation in low‐resource settings

AD Ware, C Jacquot, AAR Tobian, EA Gehrie… - Vox …, 2018 - Wiley Online Library
Transfusion‐transmitted infection risk remains an enduring challenge to blood safety in
Africa. A high background incidence and prevalence of the major transfusion‐transmitted …

[图书][B] High-power laser-plasma interaction

CS Liu, VK Tripathi, B Eliasson - 2019 - books.google.com
" Laser power has increased from 100 watts in 1960 (the first laser) to terawatts in 1985
through the invention of chirped pulse amplification proposed by Mourou and Strickland, to …

Pathogen reduction of whole blood: utility and feasibility

JP Allain, R Goodrich - Transfusion Medicine, 2017 - Wiley Online Library
Objectives To collect information on pathogen reduction applied to whole blood.
Background Pathogen reduction (PR) of blood components has been developed over the …

Risks associated with red blood cell transfusions: potential benefits from application of pathogen inactivation

S Kleinman, A Stassinopoulos - Transfusion, 2015 - Wiley Online Library
BACKGROUND Red blood cell (RBC) transfusion risks could be reduced if a robust
technology for pathogen inactivation of RBC (PI‐RBCs) were to be approved. MATERIALS …

The Mirasol Evaluation of Reduction in Infections Trial (MERIT): study protocol for a randomized controlled clinical trial

R Kasirye, HA Hume, EM Bloch, I Lubega, D Kyeyune… - Trials, 2022 - Springer
Abstract Background Transfusion-transmitted infections (TTIs) are a global health challenge.
One new approach to reduce TTIs is the use of pathogen reduction technology (PRT). In …

Red blood cells derived from whole blood treated with riboflavin and ultraviolet light maintain adequate survival in vivo after 21 days of storage

JA Cancelas, SJ Slichter, N Rugg, PG Pratt… - …, 2017 - Wiley Online Library
BACKGROUND Pathogen reduction (PR) of whole blood (WB) may increase blood safety
when applied before component separation. This study evaluates the in vivo performance of …

Treatment of whole blood with riboflavin and UV light: impact on malaria parasite viability and whole blood storage

S Owusu-Ofori, J Kusi, A Owusu-Ofori, G Freimanis… - Shock, 2015 - journals.lww.com
ABSTRACT Background: Sub-Saharan African countries utilize whole blood (WB) to treat
severe anemia secondary to severe blood loss or malaria on an emergency basis. In many …